Berkeley Lights, Inc. operates as a biotechnology company. The Company provides technology solutions for single cell manipulation for biopharma, diagnostics, and life science research. Berkeley Lights serves customers worldwide.

Company profile
Ticker
BLI
Exchange
Website
CEO
Eric Hobbs
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Agilent • Bio-Rad Laboratories • Waters • Illumina • Avantor • Mettler-Toledo International • Bruker • Perkinelmer • Seer • Cue Health ...
SEC CIK
Corporate docs
Subsidiaries
BLI Europe International, Ltd. • BLI International LLC • (Shanghai) Co., Ltd. • (Singapore) Pte., Ltd. ...
IRS number
352415390
BLI stock data
Latest filings (excl ownership)
425
Business combination disclosure
16 Mar 23
8-K
Submission of Matters to a Vote of Security Holders
16 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
424B3
Prospectus supplement
9 Mar 23
425
Business combination disclosure
7 Mar 23
425
Business combination disclosure
6 Mar 23
8-K
Unaudited Pro Forma Condensed Combined Financial Statements
6 Mar 23
424B3
Prospectus supplement
2 Mar 23
425
Business combination disclosure
28 Feb 23
S-8
Registration of securities for employees
27 Feb 23
Transcripts
BLI
Earnings call transcript
2022 Q4
23 Feb 23
BLI
Earnings call transcript
2022 Q3
9 Nov 22
BLI
Earnings call transcript
2022 Q2
10 Aug 22
BLI
Earnings call transcript
2022 Q1
10 May 22
BLI
Earnings call transcript
2021 Q4
24 Feb 22
BLI
Earnings call transcript
2021 Q3
4 Nov 21
BLI
Earnings call transcript
2021 Q2
11 Aug 21
BLI
Earnings call transcript
2021 Q1
11 May 21
BLI
Earnings call transcript
2020 Q4
28 Feb 21
BLI
Earnings call transcript
2020 Q3
12 Nov 20
Latest ownership filings
SC 13G
Nierenberg Investment Management Company, Inc.
9 Mar 23
4
Siddhartha Kadia
7 Mar 23
4
James Paul McClaskey
7 Mar 23
4
Mehul Joshi
7 Mar 23
4
James Paul McClaskey
22 Feb 23
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
SC 13G/A
BlackRock Inc.
1 Feb 23
4
James Paul McClaskey
24 Jan 23
4
Siddhartha Kadia
13 Dec 22
4
Siddhartha Kadia
9 Dec 22
Financial summary
Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 86.52 mm | 86.52 mm | 86.52 mm | 86.52 mm | 86.52 mm | 86.52 mm |
Cash burn (monthly) | 11.37 mm | 7.65 mm | 9.90 mm | 8.20 mm | 3.35 mm | 3.96 mm |
Cash used (since last report) | 30.63 mm | 20.61 mm | 26.66 mm | 22.08 mm | 9.01 mm | 10.67 mm |
Cash remaining | 55.90 mm | 65.91 mm | 59.86 mm | 64.44 mm | 77.51 mm | 75.85 mm |
Runway (months of cash) | 4.9 | 8.6 | 6.0 | 7.9 | 23.2 | 19.1 |
Institutional ownership, Q4 2022
77.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 114 |
Opened positions | 21 |
Closed positions | 16 |
Increased positions | 42 |
Reduced positions | 34 |
13F shares | Current |
---|---|
Total value | 114.30 bn |
Total shares | 55.56 mm |
Total puts | 6.50 k |
Total calls | 42.00 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Igor Y Khandros | 8.78 mm | $159.68 mm |
BLK Blackrock | 4.64 mm | $12.45 bn |
MKFCF Mackenzie Financial | 4.17 mm | $11.17 bn |
Vanguard | 3.21 mm | $8.60 bn |
Nierenberg Investment Management | 3.16 mm | $8.46 bn |
ARK Investment Management | 2.76 mm | $7.40 bn |
Glenview Capital Management | 2.61 mm | $7.00 bn |
FHI Federated Hermes | 2.14 mm | $5.72 bn |
Monaco Asset Management SAM | 1.53 mm | $4.11 bn |
JPM JPMorgan Chase & Co. | 1.39 mm | $3.73 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Mar 23 | Mehul Joshi | Common Stock | Payment of exercise | Dispose F | No | No | 1.65 | 14,818 | 24.45 k | 516,942 |
7 Mar 23 | James Paul McClaskey | Common Stock | Payment of exercise | Dispose F | No | No | 1.65 | 10,747 | 17.73 k | 128,117 |
3 Mar 23 | Mehul Joshi | Common Stock | Grant | Acquire A | No | No | 0 | 242,404 | 0.00 | 529,760 |
3 Mar 23 | James Paul McClaskey | Common Stock | Grant | Acquire A | No | No | 0 | 75,269 | 0.00 | 138,864 |
3 Mar 23 | Siddhartha Kadia | Common Stock | Grant | Acquire A | No | No | 0 | 317,029 | 0.00 | 1,240,689 |
20 Feb 23 | James Paul McClaskey | Common Stock | Payment of exercise | Dispose F | No | No | 1.65 | 1,158 | 1.91 k | 63,595 |
20 Feb 23 | James Paul McClaskey | Common Stock | Payment of exercise | Dispose F | No | No | 1.65 | 272 | 448.80 | 64,753 |
20 Feb 23 | James Paul McClaskey | Common Stock | Payment of exercise | Dispose F | No | No | 1.65 | 47 | 77.55 | 65,025 |
20 Jan 23 | James Paul McClaskey | Common Stock | Payment of exercise | Dispose F | No | No | 2.22 | 143 | 317.46 | 65,072 |
Press releases
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
21 Mar 23
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLI, DCT, ANGN
2 Mar 23
Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results
23 Feb 23
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLI, FMIA, GRAY
15 Feb 23
ISOPLEXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IsoPlexis Corporation - ISO
14 Feb 23